Navigation Links
Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
Date:5/14/2012

Grand Rapids, Mich. (May 14, 2012) - A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.

Bile Duct Cancer, or Cholangiocarcinoma, is a fatal cancer with a poor prognosis. Accounting for 10 to 25 per cent of all primary liver cancers worldwide, bile duct cancer is a prevalent disease in Southeast Asia, particularly in Northeast Thailand, which sees about 20,000 new cases each year. The high incidence in Thailand is attributed to long-term consumption of raw fish infected with liver flukes food-borne parasites found in fish. Liver fluke infections are widespread in Northeast Thailand, where they are thought to occur in over 6 million people. Once eaten, the flukes accumulate in the bile ducts of the human host, causing constant infection and eventually the onset of cancer.

The research team was led by Bin Tean Teh, M.D., Ph.D., Director and Principal Investigator of the NCCS-VARI Translational Cancer Research Laboratory. Van Andel Research Institute (VARI) and the National Cancer Center, Singapore (NCCS) established the NCCS-VARI Translational Research Program at the National Cancer Center, Singapore in 2007. The program focuses on the biology behind varying drug responses in Asian versus non-Asian patients with specific types of cancer.

The team also included Associate Professor Patrick Tan, Associate Professor Steve Rozen (both of Duke-NUS Graduate Medical School of Singapore) and Professor Vajarabhongsa Bhudhisawasdi from Thailand's Khon Kaen University. The breakthrough came after two years of intensive research, which saw scientists from Singapore visiting the villagers in northern Thailand, and Thai researche
'/>"/>

Contact: Tim Hawkins
tim.hawkins@vai.org
616-234-5519
Van Andel Research Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 Beckman Coulter is sponsoring ... Analysis,” with Borries Demeler, which will highlight approaches used ... webinar is free to attend and will be broadcast ... recent years, sophisticated new methods for sedimentation data ... AUC technology in a wide range of technology sectors, ...
(Date:3/31/2015)... Horizon Blue Cross Blue Shield of New ... combat health insurance fraud resulted in $45.4 million in ... and losses avoided -- in 2014. The $45.4 million ... its fraud fighting, Special Investigations Unit (SIU) in 1983. ... members $261 million. , “Our SIU has progressively ...
(Date:3/31/2015)... March 31, 2015 St. Joseph Medical ... network of leading healthcare systems, major physician groups and ... for the benefit of patients. The health information exchange ... supports well coordinated care throughout the continuum of services ... long tradition of providing services to a broad cross ...
(Date:3/31/2015)... 2015 The Denver Regional Council of ... planning an array of public activities which include invitations ... and a Unity Parade and Rally at Denver Union ... – a national day of advocacy on April 9 ... funding. , The effort is being led by the ...
(Date:3/31/2015)... 31, 2015 Juvent Sports ( http://www.juventsports.com ... PGA Merchandise show in Orlando. At the show, former ... Maggie Will was interviewed and she shared the life-changing ... since she began integrating the Juvent Pro Micro-Impact Platform™ ... been so instrumental to her chronic back pain recovery ...
Breaking Medicine News(10 mins):Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 2Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 3Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:St. Joseph Medical Center Joins Other Leading Healthcare Systems Participating in Greater Houston Healthconnect 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 3Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 3
... 7 Natural Alternatives International, Inc. ("NAI") (Nasdaq: ... and marketer of customized nutritional supplements, today announced ... Randell Weaver,s employment with NAI ended.NAI also announced ... with Wells Fargo Bank. Among other changes ...
... Legislation Aimed at Protecting Medicare Beneficiaries Introduced on ... 7 Physical therapy ... limited by arbitrary financial caps under legislation introduced ... according to the American Physical Therapy Association (APTA). ...
... Acute lymphoblastic leukemia is most common pediatric cancer , , ... leukemia cells predicts which children with acute lymphoblastic leukemia ... online Jan. 7 in the New England Journal ... physicians fine-tune treatment for different subsets of patients. , ...
... SB 203, known as Emily,s Law, has received ... in the state of Ohio. Named after Emily Jerry, ... pharmacy technicians. The law, which was originally sponsored by ... National Pharmacy Technician Association. Emily,s Story , Emily ...
... used to treat heart failure, slowed cell growth, study ... a drug used for many years to treat irregular ... cancer-fighting agent, researchers report. , Cancer cells need to ... these cells are oxygen-deprived and need to switch on ...
... A medical revolution emerges when,technology blends with smart ... new Smart OR(TM) - a specialized neurosurgical suite ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081016/CLTH057 ... configuration of advanced imagery and mapping technology, the ...
Cached Medicine News:Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 2Health News:Senate and House Introduce Legislation to Repeal Therapy Caps 3Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3Health News:Heart Drug May Be a Cancer Fighter 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 2Health News:A New, 'Smart' Approach to Brain and Spine Surgery 3
(Date:3/31/2015)... AUBURN HILLS, Mich. , March 31, 2015 /PRNewswire-USNewswire/ ... xenon (PU-UX) was highlighted in a recently published study ... an influential infection prevention research team, including Curtis ... robot which was run for the same length of ... a pulsed xenon (PU-UV) unit.  The results showed surprisingly ...
(Date:3/31/2015)... Accelerated orthodontic treatment will be a ... 2015 Annual Session, May 15-19, as seven of ... AcceleDent ® . Manufactured by OrthoAccel ® ... is a FDA-cleared, Class II medical device that ... 50 percent with just 20 minutes of daily ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... report "Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, ... Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - ... global Life Science and Chemical Instrumentation Market is ... CAGR of 6.9% from 2014 to 2019. ...
Breaking Medicine Technology:VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 2Leading Orthodontists to Advance Accelerated Treatment at AAO 2015 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5
... -- ImClone,Systems Incorporated and Bristol-Myers Squibb Company ... ERBITUX(R) (Cetuximab) plus,gemcitabine (a chemotherapy) in patients ... did not meet its,primary endpoint of improving ... Oncology Group (SWOG), a cancer,center network sponsored ...
... ALTO, Calif., April 09, 2007 /PRNewswire-FirstCall/ --,Telik, ... its,multicenter Phase 2 trial of the triplet ... paclitaxel will be,presented at the 98th annual ... (AACR) in Los Angeles. Preclinical studies of,cellular ...
Cached Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: